These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 16029442)

  • 1. Extranodal mantle cell lymphoma in a prolapsed ileostomy stump.
    Robinson H; Rymes N
    Br J Haematol; 2005 Jul; 130(2):151. PubMed ID: 16029442
    [No Abstract]   [Full Text] [Related]  

  • 2. Education and imaging. Gastrointestinal: mantle cell lymphoma diagnosed by balloon enteroscopy.
    Yumori A; Okubo H; Takahashi H; Iida H; Mawatari H; Yoneda M; Inamori M; Abe Y; Kobayashi N; Kirikoshi H; Kubota K; Saito S; Nakajima A
    J Gastroenterol Hepatol; 2008 Oct; 23(10):1623. PubMed ID: 19120850
    [No Abstract]   [Full Text] [Related]  

  • 3. Combined cyclophosphamide, vincristine, doxorubicin, and prednisone (CHOP) improves response rates but not survival and has lower hematologic toxicity compared with combined mitoxantrone, chlorambucil, and prednisone (MCP) in follicular and mantle cell lymphomas: results of a prospective randomized trial of the German Low-Grade Lymphoma Study Group.
    Nickenig C; Dreyling M; Hoster E; Pfreundschuh M; Trumper L; Reiser M; Wandt H; Lengfelder E; Unterhalt M; Hiddemann W;
    Cancer; 2006 Sep; 107(5):1014-22. PubMed ID: 16878325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Mantle cell lymphoma mimicking chronic lymphocytic leukemia].
    Hanamura A; Hayakawa M; Naito K
    Rinsho Ketsueki; 2005 Jan; 46(1):13-8. PubMed ID: 16708912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activity and safety of combined rituximab with chlorambucil in patients with mantle cell lymphoma.
    Bauwens D; Maerevoet M; Michaux L; Théate I; Hagemeijer A; Stul M; Danse E; Costantini S; Vannuffel P; Straetmans N; Vekemans MC; Deneys V; Ferrant A; Van Den Neste E
    Br J Haematol; 2005 Nov; 131(3):338-40. PubMed ID: 16225653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Common malignancies with uncommon sites of presentation: case 2. Mantle-cell lymphoma of the prostate.
    Chim CS; Loong F; Yau T; Ooi GC; Liang R
    J Clin Oncol; 2003 Dec; 21(23):4456-8. PubMed ID: 14645437
    [No Abstract]   [Full Text] [Related]  

  • 7. Successful treatment of focal segmental glomerulosclerosis in association with mantle cell lymphoma.
    Wong CF; Mohteshamzadeh M; Arsalanizadeh B; Dutt T; Shawki H; Khine MM; Rustom R
    Ren Fail; 2007; 29(3):363-6. PubMed ID: 17497453
    [No Abstract]   [Full Text] [Related]  

  • 8. Phase 2 trial of rituximab plus hyper-CVAD alternating with rituximab plus methotrexate-cytarabine for relapsed or refractory aggressive mantle cell lymphoma.
    Wang M; Fayad L; Cabanillas F; Hagemeister F; McLaughlin P; Rodriguez MA; Kwak LW; Zhou Y; Kantarjian H; Romaguera J
    Cancer; 2008 Nov; 113(10):2734-41. PubMed ID: 18973182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. R-CHOP for mantle cell lymphoma.
    Klumpp TR
    J Clin Oncol; 2005 Sep; 23(27):6802; author reply 6802-3. PubMed ID: 16170194
    [No Abstract]   [Full Text] [Related]  

  • 10. Mantle-cell lymphoma (multiple lymphomatous polyposis) of the entire GI tract.
    Michopoulos S; Petraki K; Matsouka C; Kastritis E; Chrysanthopoulou H; Dimopoulos MA
    J Clin Oncol; 2008 Mar; 26(9):1555-7. PubMed ID: 18349408
    [No Abstract]   [Full Text] [Related]  

  • 11. CD5-undetected by immunohistochemistry, t(11;14)(q13;q32)-positive conjunctival mantle cell lymphoma: a case report.
    Yoo SB; Kim YA; Jeon YK; Kim CW
    Pathol Res Pract; 2008; 204(10):779-83. PubMed ID: 18572329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intestinal mantle cell lymphoma observed by double-balloon endoscopy with Fuji Intelligent Chromo Endoscopy.
    Norimura D; Isomoto H; Niino D; Akazawa Y; Yamaguchi N; Ohnita K; Shikuwa S; Takeshima F; Nakao K
    Endoscopy; 2011; 43 Suppl 2 UCTN():E26-7. PubMed ID: 21271526
    [No Abstract]   [Full Text] [Related]  

  • 13. Primary cutaneous mantle cell lymphoma.
    Zattra E; Zambello R; Marino F; Bordignon M; Alaibac M
    Acta Derm Venereol; 2011 Jun; 91(4):474-5. PubMed ID: 21537825
    [No Abstract]   [Full Text] [Related]  

  • 14. High rate of durable remissions after treatment of newly diagnosed aggressive mantle-cell lymphoma with rituximab plus hyper-CVAD alternating with rituximab plus high-dose methotrexate and cytarabine.
    Romaguera JE; Fayad L; Rodriguez MA; Broglio KR; Hagemeister FB; Pro B; McLaughlin P; Younes A; Samaniego F; Goy A; Sarris AH; Dang NH; Wang M; Beasley V; Medeiros LJ; Katz RL; Gagneja H; Samuels BI; Smith TL; Cabanillas FF
    J Clin Oncol; 2005 Oct; 23(28):7013-23. PubMed ID: 16145068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Front-line treatment of mantle cell lymphoma.
    Geisler CH
    Haematologica; 2010 Aug; 95(8):1241-3. PubMed ID: 20675744
    [No Abstract]   [Full Text] [Related]  

  • 16. [Extranodal lymphoma from mantle cells with involvement of the orbit].
    Krasil'nikova BB; Zvonkov EE; Obukhova TN; Kravchenko SK; Sindeeva IuN; Efimov IV; Kaplanskaia IB; Kremenetskaia AM; Makhinia VA; Samoĭlova RS; Lorie IuIu
    Ter Arkh; 2005; 77(7):83-5. PubMed ID: 16116917
    [No Abstract]   [Full Text] [Related]  

  • 17. Bullous pemphigoid associated with mantle cell lymphoma.
    Iranzo P; López I; Robles MT; Mascaró JM; Campo E; Herrero C
    Arch Dermatol; 2004 Dec; 140(12):1496-9. PubMed ID: 15611428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The hyper-CVAD-rituximab chemotherapy programme followed by high-dose busulfan, melphalan and autologous stem cell transplantation produces excellent event-free survival in patients with previously untreated mantle cell lymphoma.
    Ritchie DS; Seymour JF; Grigg AP; Roberts AW; Hoyt R; Thompson S; Szer J; Prince HM
    Ann Hematol; 2007 Feb; 86(2):101-5. PubMed ID: 17089127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mantle cell lymphoma of the iris.
    Economou MA; Kopp ED; All-Ericsson C; Seregard S
    Acta Ophthalmol Scand; 2007 May; 85(3):341-3. PubMed ID: 17488468
    [No Abstract]   [Full Text] [Related]  

  • 20. Rituximab and DHAP followed by intensive therapy with autologous stem-cell transplantation as first-line therapy for mantle cell lymphoma.
    de Guibert S; Jaccard A; Bernard M; Turlure P; Bordessoule D; Lamy T
    Haematologica; 2006 Mar; 91(3):425-6. PubMed ID: 16531272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.